Brain Cancer Trial, Recruiting NCT07415668 Sponsor: Insel Gruppe AG, University Hospital Bern Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT07415668
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing and able to give informed consent to participate
  • People who are 18 years of age or older
  • People who have a brain metastasis (a cancer that has spread to the brain) that is located in or very close to the part of the brain that controls movement (the primary motor cortex), within 10 millimetres of it
  • People who are having surgery to remove the brain tumour
  • People whose treating team has planned a specific type of targeted radiation treatment (called radiosurgery/SRS) after surgery, to be carried out at Inselspital Bern

Who may not be able to join:

  • People who have certain implants or medical devices that are not compatible with a brain stimulation technique called TMS — this includes cochlear implants, pacemakers, deep brain stimulation electrodes, or other metallic or electrical implants (excluding dental work or standard post-surgery craniotomy hardware) (confirm with trial site)
  • People who have conditions such as Meniere's disease, uncontrolled seizures, significant ringing in the ears (tinnitus), depression diagnosed by a specialist, or psychosis
  • People who have previously had radiation treatment to the same area of the brain affected by the current tumour, if it would interfere with the planned radiosurgery
  • People for whom whole-brain radiation therapy is planned
  • People who have a second brain lesion within 2 centimetres of the current tumour, on the same side of the brain, in the motor cortex area
  • People who have had an infection or wound healing problems in the two weeks before joining the trial
  • People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Insel Gruppe AG, University Hospital Bern
Registry
ClinicalTrials.gov
Start date
8 May 2026
Est. completion
30 April 2029

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Within-patient difference in maximum dose

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov